Andrew Woolley is a scientist driven to capture how therapeutic technologies alter cells and tissues.
Dr. Woolley's research utilizes advanced bio-imaging and quantification tools, along with novel surgical, histological and cytological techniques. Dr. Woolley holds the role of Principal Scientist in Translational Histopathology at Bristol Myers Squibb in the Bay Area. His work informs the development of clinical technologies through cutting edge experimental research and data analysis. LinkedIn . Google Scholar . Research Gate . Academia.edu Bio: Andrew Woolley is a biotech scientist in the San Francisco Bay Area. He received a PhD in Integrated Neurosciences from Purdue University in 2011, developing novel histological methods to characterize the biological impact of brain-implanted microdevices. He continued as a DARPA-funded postdoc in the Dept. of Biomedical Engineering at Purdue before moving to Australia, where he became a postdoc within the 'Bionic Vision Australia' consortium. In this role he worked at UNSW in Sydney to image the biological integration and electrical excitation strategies of visual prostheses technologies currently in clinical and pre-clinical testing. Andrew has helped supervise 3 PhD, 2 Masters, and many Undergraduate students, has published numerous research papers, and holds membership in multiple professional research societies. His research images have earned awards in Nikon 'Small Worlds', Olympus 'BioScapes', and other imaging contests, and have appeared in Scientific American and other popular press publications. |
© COPYRIGHT 2015. ALL RIGHTS RESERVED.
|